Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013351736> ?p ?o ?g. }
- W2013351736 abstract "Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, ILBackground: The role of cleaved caspase-3 as an integral player in the apoptotic process of mammalian cells has prompted the investigation of an assay to detect cleaved caspase-3 in circulating tumor cells (CTCs) as one way to assess CTC viability. Methods: Using a previously developed non-enrichment based assay, nucleated blood cells and CTCs are adhered to a single slide. An antibody for cleaved caspase-3 was incorporated into the assay in addition to the existing antibodies for cytokeratin (to identify tumor cells) and CD45 (to identify white blood cells), as well as a nuclear stain (DAPI). The modified assay was initially tested on cultured MCF 10a cells spiked into normal donor blood. Before spiking, apoptosis was induced in these cells using staurosporine. Following validation of the assay in cell lines, the assay was performed using blood samples from 9 different breast cancer patients, as well as 3 different normal donor samples. Results: CTCs were detected in the patient samples as single cells, as well as clusters. The results of the assay showed that only 1 out of 896 detected CTCs was positive for cleaved caspase-3 (0.11%). Of these CTCs, 134 of them were found to be in clusters, and all 134 were negative for cleaved caspase-3, indicating that whether in clusters or as single cells, the vast majority of CTC's detected with this assay are not undergoing irreversible apoptotic processes via cleaved caspase-3. The results also showed that 0.40% of white blood cells in healthy donors expressed cleaved caspase-3, compared to 0.51% of the white cells in cancer patients, indicating that healthy donors and cancer patients express cleaved caspase-3 in their white blood cells at nearly the same rate. Conclusions: The morphologic characterization used in this platform to select healthy-appearing cells identifies a population of circulating tumor cells with virtually no evidence of caspase-related ongoing apoptosis, a finding that supports the morphologic impression of viability.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3619. doi:1538-7445.AM2012-3619" @default.
- W2013351736 created "2016-06-24" @default.
- W2013351736 creator A5000472988 @default.
- W2013351736 creator A5002307414 @default.
- W2013351736 creator A5011000431 @default.
- W2013351736 creator A5031571336 @default.
- W2013351736 creator A5032892920 @default.
- W2013351736 creator A5038373313 @default.
- W2013351736 creator A5046869833 @default.
- W2013351736 creator A5069092297 @default.
- W2013351736 creator A5071469591 @default.
- W2013351736 creator A5081125472 @default.
- W2013351736 date "2012-04-15" @default.
- W2013351736 modified "2023-09-26" @default.
- W2013351736 title "Abstract 3619: The absence of cleaved caspase-3 in circulating tumor cells detected using a non-enrichment-based assay" @default.
- W2013351736 doi "https://doi.org/10.1158/1538-7445.am2012-3619" @default.
- W2013351736 hasPublicationYear "2012" @default.
- W2013351736 type Work @default.
- W2013351736 sameAs 2013351736 @default.
- W2013351736 citedByCount "1" @default.
- W2013351736 countsByYear W20133517362014 @default.
- W2013351736 crossrefType "proceedings-article" @default.
- W2013351736 hasAuthorship W2013351736A5000472988 @default.
- W2013351736 hasAuthorship W2013351736A5002307414 @default.
- W2013351736 hasAuthorship W2013351736A5011000431 @default.
- W2013351736 hasAuthorship W2013351736A5031571336 @default.
- W2013351736 hasAuthorship W2013351736A5032892920 @default.
- W2013351736 hasAuthorship W2013351736A5038373313 @default.
- W2013351736 hasAuthorship W2013351736A5046869833 @default.
- W2013351736 hasAuthorship W2013351736A5069092297 @default.
- W2013351736 hasAuthorship W2013351736A5071469591 @default.
- W2013351736 hasAuthorship W2013351736A5081125472 @default.
- W2013351736 hasConcept C121608353 @default.
- W2013351736 hasConcept C12519072 @default.
- W2013351736 hasConcept C126322002 @default.
- W2013351736 hasConcept C142724271 @default.
- W2013351736 hasConcept C153911025 @default.
- W2013351736 hasConcept C159654299 @default.
- W2013351736 hasConcept C181199279 @default.
- W2013351736 hasConcept C185592680 @default.
- W2013351736 hasConcept C190283241 @default.
- W2013351736 hasConcept C195794163 @default.
- W2013351736 hasConcept C203014093 @default.
- W2013351736 hasConcept C204232928 @default.
- W2013351736 hasConcept C2777527632 @default.
- W2013351736 hasConcept C2779012181 @default.
- W2013351736 hasConcept C2779013556 @default.
- W2013351736 hasConcept C2779084600 @default.
- W2013351736 hasConcept C31573885 @default.
- W2013351736 hasConcept C502942594 @default.
- W2013351736 hasConcept C55493867 @default.
- W2013351736 hasConcept C61238886 @default.
- W2013351736 hasConcept C71924100 @default.
- W2013351736 hasConcept C86803240 @default.
- W2013351736 hasConcept C96232424 @default.
- W2013351736 hasConceptScore W2013351736C121608353 @default.
- W2013351736 hasConceptScore W2013351736C12519072 @default.
- W2013351736 hasConceptScore W2013351736C126322002 @default.
- W2013351736 hasConceptScore W2013351736C142724271 @default.
- W2013351736 hasConceptScore W2013351736C153911025 @default.
- W2013351736 hasConceptScore W2013351736C159654299 @default.
- W2013351736 hasConceptScore W2013351736C181199279 @default.
- W2013351736 hasConceptScore W2013351736C185592680 @default.
- W2013351736 hasConceptScore W2013351736C190283241 @default.
- W2013351736 hasConceptScore W2013351736C195794163 @default.
- W2013351736 hasConceptScore W2013351736C203014093 @default.
- W2013351736 hasConceptScore W2013351736C204232928 @default.
- W2013351736 hasConceptScore W2013351736C2777527632 @default.
- W2013351736 hasConceptScore W2013351736C2779012181 @default.
- W2013351736 hasConceptScore W2013351736C2779013556 @default.
- W2013351736 hasConceptScore W2013351736C2779084600 @default.
- W2013351736 hasConceptScore W2013351736C31573885 @default.
- W2013351736 hasConceptScore W2013351736C502942594 @default.
- W2013351736 hasConceptScore W2013351736C55493867 @default.
- W2013351736 hasConceptScore W2013351736C61238886 @default.
- W2013351736 hasConceptScore W2013351736C71924100 @default.
- W2013351736 hasConceptScore W2013351736C86803240 @default.
- W2013351736 hasConceptScore W2013351736C96232424 @default.
- W2013351736 hasLocation W20133517361 @default.
- W2013351736 hasOpenAccess W2013351736 @default.
- W2013351736 hasPrimaryLocation W20133517361 @default.
- W2013351736 hasRelatedWork W1531653295 @default.
- W2013351736 hasRelatedWork W1968650798 @default.
- W2013351736 hasRelatedWork W1993238757 @default.
- W2013351736 hasRelatedWork W2057169176 @default.
- W2013351736 hasRelatedWork W2131251569 @default.
- W2013351736 hasRelatedWork W2236447015 @default.
- W2013351736 hasRelatedWork W2303440448 @default.
- W2013351736 hasRelatedWork W2313167943 @default.
- W2013351736 hasRelatedWork W2320851593 @default.
- W2013351736 hasRelatedWork W2324170616 @default.
- W2013351736 hasRelatedWork W2327335165 @default.
- W2013351736 hasRelatedWork W2329608855 @default.
- W2013351736 hasRelatedWork W2335057514 @default.
- W2013351736 hasRelatedWork W2360013753 @default.
- W2013351736 hasRelatedWork W2385333424 @default.
- W2013351736 hasRelatedWork W2588380004 @default.
- W2013351736 hasRelatedWork W2727916905 @default.
- W2013351736 hasRelatedWork W2799496787 @default.
- W2013351736 hasRelatedWork W3030455553 @default.